Influenza A viruses: New research developments

Nature Reviews Microbiology

Volumn 9, Issue 8, 2011, Pages 590-603

  Medina, Rafael A ^a   García Sastre, Adolfo ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; HUMORAL IMMUNITY; INFLUENZA A; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRAL TROPISM; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; EVOLUTION, MOLECULAR; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MODELS, BIOLOGICAL; ORTHOMYXOVIRIDAE INFECTIONS; PANDEMICS; VIRAL TROPISM; VIRULENCE; ZOONOSES;

ANIMALIA; AVES; EQUIDAE; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 79960384534     PISSN: 17401526     EISSN: 17401534     Source Type: Journal    
DOI: 10.1038/nrmicro2613     Document Type: Review

References (154)

1. Molinari, N. A. et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 25, 5086-5096 (2007).
2. Johnson, N. P. & Mueller, J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull. Hist. Med. 76, 105-115 (2002).
3. Palese, P. & Shaw, M. L. in Fields Virology 5th edn (eds Knipe, D. M. et al.) 1647-1689 (Lippincott Williams & Wilkins, Philadelphia, USA, 2007).
4. Wise, H. M. et al. A complicated message: identification of a novel PB1-related protein translated from influenza A virus segment 2 mRNA. J. Virol. 83, 8021-8031 (2009).
5. Fouchier, R. A. et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79, 2814-2822 (2005). (Pubitemid 40270559)
6. Russell, R. J. et al. H1 and H7 influenza haemagglutinin structures extend a structural classification of haemagglutinin subtypes. Virology 325, 287-296 (2004). (Pubitemid 38902794)
7. Nobusawa, E. et al. Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A viruses. Virology 182, 475-485 (1991).
8. Air, G. M. Sequence relationships among the hemagglutinin genes of 12 subtypes of influenza A virus. Proc. Natl Acad. Sci. USA 78, 7639-7643 (1981). (Pubitemid 12186198)
9. Wright, P. F., Neumann, G., & Kawaoka, Y. in Fields Virology 5th edn (eds Knipe, D. M. et al.) 1691-1740 (Lippincott Williams & Wilkins, Philadelphia, USA, 2007).
10. WHO. Pandemic (H1N1) 2009-update 109. WHO Global Alert and Response [online], http://www.who.int/csr/don/2010-07-16/en/index.html (2009).
11. CDC. Updated CDC estimates of 2009 H1N1 influenza cases, hospitalizations and deaths in the United States, April 2009-April 10, 2010. CDC [online], http://www.cdc.gov/h1n1flu/pdf/CDC-2009-H1N1-Est-PDF-May-4-10-fulltext.pdf (2010).
12. Brown, I. H. Summary of avian influenza activity in Europe, Asia, and Africa, 2006-2009. Avian Dis. 54, 187-193 (2010).
13. Senne, D. A. Avian influenza in North and South America, the Caribbean, and Australia, 2006-2008. Avian Dis. 54, 179-186 (2010).
14. Krauss, S. et al. Influenza in migratory birds and evidence of limited intercontinental virus exchange. PLoS Pathog. 3, e167 (2007).
15. Obenauer, J. C. et al. Large-scale sequence analysis of avian influenza isolates. Science 311, 1576-1580 (2006).
16. Vijaykrishna, D. et al. Evolutionary dynamics and emergence of panzootic H5N1 influenza viruses. PLoS Pathog. 4, e1000161 (2008).
17. Claas, E. C. et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351, 472-477 (1998). (Pubitemid 28070093)
18. WHO. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. WHO Global Alert and Response [online], http://www.who.int/csr/disease/avian-influenza/country/cases-table-2011-06-22/ en/index.html (2011).
19. Li, K. S. et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 430, 209-213 (2004). (Pubitemid 38902429)
20. WHO. Continuing progress towards a unified nomenclature system for the highly pathogenic H5N1 avian influenza viruses. WHO [online], http://www.who.int/csr/disease/avian-influenza/guidelines/nomenclature/en/index. html (2009).
21. WHO/OIE/FAO H5N1 Evolution Working Group. Toward a unified nomenclature system for highly pathogenic avian influenza virus (H5N1). Emerg. Infect. Dis. 14, e1 (2008).
22. Jackson, D., Hossain, M. J., Hickman, D., Perez, D. R. & Lamb, R. A. A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc. Natl Acad. Sci. USA 105, 4381-4386 (2008). (Pubitemid 351754389)
23. Dugan, V. G. et al. The evolutionary genetics and emergence of avian influenza viruses in wild birds. PLoS Pathog. 4, e1000076 (2008).
24. Chen, H. et al. Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature 436, 191-192 (2005). (Pubitemid 41021261)
25. Chen, H. et al. Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc. Natl Acad. Sci. USA 103, 2845-2850 (2006).
26. Smith, G. J. et al. Emergence and predominance of an H5N1 influenza variant in China. Proc. Natl Acad. Sci. USA 103, 16936-16941 (2006). (Pubitemid 44737356)
27. Fouchier, R. A. et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl Acad. Sci. USA 101, 1356-1361 (2004). (Pubitemid 38182693)
28. Koopmans, M. et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363, 587-593 (2004). (Pubitemid 38264175)
29. Peiris, M. et al. Human infection with influenza H9N2. Lancet 354, 916-917 (1999). (Pubitemid 29424025)
30. Lin, Y. P. et al. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc. Natl Acad. Sci. USA 97, 9654-9658 (2000). (Pubitemid 30650831)
31. Malik Peiris, J. S. Avian influenza viruses in humans. Rev. Sci. Tech. 28, 161-173 (2009).
32. Kalthoff, D., Globig, A. & Beer, M. (Highly pathogenic) avian influenza as a zoonotic agent. Vet. Microbiol. 140, 237-245 (2010).
33. Dong, G. et al. Phylogenetic diversity and genotypical complexity of H9N2 influenza A viruses revealed by genomic sequence analysis. PLoS ONE 6, e17212 (2011).
34. Xu, K. M. et al. The genesis and evolution of H9N2 influenza viruses in poultry from southern China, 2000 to 2005. J. Virol. 81, 10389-10401 (2007). (Pubitemid 47463313)
35. Song, X. F., Han, P. & Chen, Y. P. Genetic variation of the hemagglutinin of avian influenza virus H9N2. J. Med. Virol. 83, 838-846 (2011).
36. Bulach, D. et al. Molecular analysis of H7 avian influenza viruses from Australia and New Zealand: genetic diversity and relationships from 1976 to 2007. J. Virol. 84, 9957-9966 (2010).
37. Munster, V. J. et al. Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe. Emerg. Infect. Dis. 11, 1545-1551 (2005). (Pubitemid 41384340)
38. Rambaut, A. et al. The genomic and epidemiological dynamics of human influenza A virus. Nature 453, 615-619 (2008). (Pubitemid 351769300)
39. Nelson, M. I. et al. Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog. 4, e1000012 (2008).
40. Holmes, E. C. et al. Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol. 3, e300 (2005).
41. Nelson, M. I. et al. Stochastic processes are key determinants of short-term evolution in influenza a virus. PLoS Pathog. 2, e125 (2006).
42. Russell, C. A. et al. The global circulation of seasonal influenza A (H3N2) viruses. Science 320, 340-346 (2008). (Pubitemid 351555652)
43. Nelson, M. I., Simonsen, L., Viboud, C., Miller, M. A. & Holmes, E. C. Phylogenetic analysis reveals the global migration of seasonal influenza A viruses. PLoS Pathog. 3, 1220-1228 (2007). (Pubitemid 47510275)
44. Lowen, A. C., Mubareka, S., Steel, J. & Palese, P. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog. 3, 1470-1476 (2007). (Pubitemid 350085611)
45. CDC. Update: influenza activity-United States, 2009-2010 season. MMWR Morb. Mortal. Wkly Rep. 59, 901-908 (2010).
46. Zepeda-Lopez, H. M. et al. Inside the outbreak of the 2009 influenza A (H1N1)v virus in Mexico. PLoS ONE 5, e13256 (2010).
47. Chao, D. L., Halloran, M. E. & Longini, I. M. Jr. School opening dates predict pandemic influenza A(H1N1) outbreaks in the United States. J. Infect. Dis. 202, 877-880 (2010).
48. Fraser, C. et al. Pandemic potential of a strain of influenza A (H1N1): early findings. Science 324, 1557-1561 (2009).
49. Garten, R. J. et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325, 197-201 (2009).
50. Smith, G. J. et al. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459, 1122-1125 (2009).
51. Kuiken, T. et al. Host species barriers to influenza virus infections. Science 312, 394-397 (2006).
52. Stevens, J. et al. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J. Mol. Biol. 355, 1143-1155 (2006). (Pubitemid 43012153)
53. Chandrasekaran, A. et al. Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin. Nature Biotech. 26, 107-113 (2008).
54. Matrosovich, M., Zhou, N., Kawaoka, Y. & Webster, R. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J. Virol. 73, 1146-1155 (1999). (Pubitemid 29036766)
55. Shinya, K. et al. Avian flu: influenza virus receptors in the human airway. Nature 440, 435-436 (2006).
56. van Riel, D. et al. H5N1 virus attachment to lower respiratory tract. Science 312, 399 (2006).
57. Ito, T. et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol. 72, 7367-7373 (1998). (Pubitemid 28377868)
58. Smith, G. J. et al. Dating the emergence of pandemic influenza viruses. Proc. Natl Acad. Sci. USA 106, 11709-11712 (2009).
59. Kimble, B., Nieto, G. R. & Perez, D. R. Characterization of influenza virus sialic acid receptors in minor poultry species. Virol. J. 7, 365 (2010).
60. Wan, H. & Perez, D. R. Quail carry sialic acid receptors compatible with binding of avian and human influenza viruses. Virology 346, 278-286 (2006). (Pubitemid 43357872)
61. Soundararajan, V. et al. Extrapolating from sequence-the 2009 H1N1 'swine' influenza virus. Nature Biotech. 27, 510-513 (2009).
62. Chen, L. M. et al. Receptor specificity of subtype H1 influenza A viruses isolated from swine and humans in the United States. Virology 412, 401-410 (2011).
63. Childs, R. A. et al. Receptor-binding specificity of pandemic influenza A (H1N1) 2009 virus determined by carbohydrate microarray. Nature Biotech. 27, 797-799 (2009).
64. Munster, V. J. et al. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325, 481-483 (2009).
65. Maines, T. R. et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325, 484-487 (2009).
66. Nicholls, J. M. et al. Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nature Med. 13, 147-149 (2007).
67. Maines, T. R. et al. Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc. Natl Acad. Sci. USA 103, 12121-12126 (2006). (Pubitemid 44215821)
68. Srinivasan, A. et al. Quantitative biochemical rationale for differences in transmissibility of 1918 pandemic influenza A viruses. Proc. Natl Acad. Sci. USA 105, 2800-2805 (2008). (Pubitemid 351723624)
69. Tumpey, T. M. et al. A two-amino acid change in the hemagglutinin of the 1918 influenza virus abolishes transmission. Science 315, 655-659 (2007). (Pubitemid 46214711)
70. Steel, J., Lowen, A. C., Mubareka, S. & Palese, P. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog. 5, e1000252 (2009).
71. Stevens, J. et al. Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus. Science 312, 404-410 (2006).
72. Yamada, S. et al. Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors. Nature 444, 378-382 (2006). (Pubitemid 44764114)
73. Gao, Y. et al. Identification of amino acids in HA and PB2 critical for the transmission of H5N1 avian influenza viruses in a mammalian host. PLoS Pathog. 5, e1000709 (2009).
74. Russell, R. J., Stevens, D. J., Haire, L. F., Gamblin, S. J. & Skehel, J. J. Avian and human receptor binding by hemagglutinins of influenza A viruses. Glycoconj. J. 23, 85-92 (2006).
75. Xu, R., McBride, R., Paulson, J. C., Basler, C. F. & Wilson, I. A. Structure, receptor binding, and antigenicity of influenza virus hemagglutinins from the 1957 H2N2 pandemic. J. Virol. 84, 1715-1721 (2010).
76. Liu, J. et al. Structures of receptor complexes formed by hemagglutinins from the Asian Influenza pandemic of 1957. Proc. Natl Acad. Sci. USA 106, 17175-17180 (2009).
77. Chan, P. K. et al. Clinical and virological course of infection with haemagglutinin D222G mutant strain of 2009 pandemic influenza A (H1N1) virus. J. Clin. Virol. 50, 320-324 (2011).
78. Kilander, A., Rykkvin, R., Dudman, S. G. & Hungnes, O. Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill. 15, 19498 (2010).
79. Chutinimitkul, S. et al. Virulence-associated substitution D222G in the hemagglutinin of 2009 pandemic influenza A(H1N1) virus affects receptor binding. J. Virol. 84, 11802-11813 (2010).
80. Liu, Y. et al. Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus. J. Virol. 84, 12069-12074 (2010).
81. Itoh, Y. et al. In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 460, 1021-1025 (2009).
82. Manicassamy, B. et al. Protection of mice against lethal challenge with 2009 H1N1 influenza a virus by 1918-like and classical swine H1N1 based vaccines. PLoS Pathog. 6, e1000745 (2010).
83. Salomon, R. et al. The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J. Exp. Med. 203, 689-697 (2006).
84. Subbarao, E. K., London, W. & Murphy, B. R. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J. Virol. 67, 1761-1764 (1993). (Pubitemid 23088345)
85. Hatta, M. et al. Growth of H5N1 influenza A viruses in the upper respiratory tracts of mice. PLoS Pathog. 3, 1374-1379 (2007). (Pubitemid 350085602)
86. de Wit, E. et al. Molecular determinants of adaptation of highly pathogenic avian influenza H7N7 viruses to efficient replication in the human host. J. Virol. 84, 1597-1606 (2010).
87. Gabriel, G. et al. The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc. Natl Acad. Sci. USA 102, 18590-18595 (2005). (Pubitemid 43011270)
88. de Jong, M. D. et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nature Med. 12, 1203-1207 (2006). (Pubitemid 44527358)
89. Van Hoeven, N. et al. Human HA and polymerase subunit PB2 proteins confer transmission of an avian influenza virus through the air. Proc. Natl Acad. Sci. USA 106, 3366-3371 (2009).
90. Perez, D. R. et al. Fitness of pandemic H1N1 and seasonal influenza A viruses during co-infection: evidence of competitive advantage of pandemic H1N1 influenza versus seasonal influenza. PLoS Curr. 1, RRN1011 (2009).
91. Mehle, A. & Doudna, J. A. Adaptive strategies of the influenza virus polymerase for replication in humans. Proc. Natl Acad. Sci. USA 106, 21312-21316 (2009).
92. Yamada, S. et al. Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog. 6 e1001034 (2010).
93. Hao, L. et al. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 454, 890-893 (2008).
94. Konig, R. et al. Human host factors required for influenza virus replication. Nature 463, 813-817 (2010).
95. Shapira, S. D. et al. A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139, 1255-1267 (2009).
96. Karlas, A. et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463, 818-822 (2010).
97. Brass, A. L. et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243-1254 (2009).
98. Watanabe, T., Watanabe, S. & Kawaoka, Y. Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 7, 427-439 (2010).
99. Yount, J. S. et al. Palmitoylome profiling reveals S-palmitoylation- dependent antiviral activity of IFITM3. Nature Chem. Biol. 6, 610-614 (2010).
100. Tumpey, T. M. et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310, 77-80 (2005). (Pubitemid 41434537)
101. Dawood, F. S. et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360, 2605-2615 (2009).
102. Hancock, K. et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N. Engl. J. Med. 361, 1945-1952 (2009).
103. Skountzou, I. et al. Immunity to pre-1950 H1N1 influenza viruses confers cross-protection against the pandemic swine-origin 2009 A (H1N1) influenza virus. J. Immunol. 185, 1642-1649 (2010).
104. Kash, J. C. et al. Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virus. Influenza Other Respi. Viruses 4, 121-127 (2010).
105. Medina, R. A. et al. Pandemic 2009 H1N1 vaccine protects against 1918 Spanish influenza virus. Nature Commun. 1, 28 (2010).
106. Xu, R. et al. Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus. Science 328, 357-360 (2010).
107. Wei, C. J. et al. Cross-neutralization of 1918 and 2009 influenza viruses: role of glycans in viral evolution and vaccine design. Sci. Transl. Med. 2, 24ra21 (2010).
108. Wang, C. C. et al. Glycans on influenza hemagglutinin affect receptor binding and immune response. Proc. Natl Acad. Sci. USA 106, 18137-18142 (2009).
109. Jang, H. et al. Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc. Natl Acad. Sci. USA 106, 14063-14068 (2009).
110. Kobasa, D. et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445, 319-323 (2007). (Pubitemid 46122819)
111. Watanabe, T. et al. Viral RNA polymerase complex promotes optimal growth of 1918 virus in the lower respiratory tract of ferrets. Proc. Natl Acad. Sci. USA 106, 588-592 (2009).
112. Pappas, C. et al. Single gene reassortants identify a critical role for PB1, HA, and NA in the high virulence of the 1918 pandemic influenza virus. Proc. Natl Acad. Sci. USA 105, 3064-3069 (2008). (Pubitemid 351723668)
113. Gibbs, J. S., Malide, D., Hornung, F., Bennink, J. R. & Yewdell, J. W. The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. J. Virol. 77, 7214-7224 (2003). (Pubitemid 36734490)
114. Chen, W. et al. A novel influenza A virus mitochondrial protein that induces cell death. Nature Med. 7, 1306-1312 (2001). (Pubitemid 34007934)
115. Zamarin, D., Garcia-Sastre, A., Xiao, X., Wang, R. & Palese, P. Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog. 1, e4 (2005).
116. Conenello, G. M., Zamarin, D., Perrone, L. A., Tumpey, T. & Palese, P. A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog. 3, 1414-1421 (2007). (Pubitemid 350085606)
117. McAuley, J. L. et al. Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2, 240-249 (2007). (Pubitemid 47500821)
118. Varga, Z. T. et al. The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog. 7, e1002067 (2011).
119. Hai, R. et al. PB1-F2 expression by the 2009 pandemic H1N1 influenza virus has minimal impact on virulence in animal models. J. Virol. 84, 4442-4450 (2010).
120. McAuley, J. L. et al. PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog. 6, e1001014 (2010).
121. Hale, B. G., Randall, R. E., Ortin, J. & Jackson, D. The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89, 2359-2376 (2008).
122. Gack, M. U. et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5, 439-449 (2009).
123. Fernandez-Sesma, A. et al. Influenza virus evades innate and adaptive immunity via the NS1 protein. J. Virol. 80, 6295-6304 (2006). (Pubitemid 43927432)
124. Nemeroff, M. E., Barabino, S. M., Li, Y., Keller, W. & Krug, R. M. Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol. Cell 1, 991-1000 (1998). (Pubitemid 128379260)
125. Beigel, J. H. et al. Avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 353, 1374-1385 (2005). (Pubitemid 41362705)
126. Seo, S. H., Hoffmann, E. & Webster, R. G. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nature Med. 8, 950-954 (2002). (Pubitemid 35033698)
127. Hale, B. G. et al. Mutations in the NS1 C-terminal tail do not enhance replication or virulence of the 2009 pandemic H1N1 influenza A virus. J. Gen. Virol. 91, 1737-1742 (2010).
128. Hale, B. G. et al. Inefficient control of host gene expression by the 2009 pandemic H1N1 influenza A virus NS1 protein. J. Virol. 84, 6909-6922 (2010).
129. Kash, J. C. et al. Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443, 578-581 (2006). (Pubitemid 44527293)
130. Perrone, L. A., Plowden, J. K., Garcia-Sastre, A., Katz, J. M. & Tumpey, T. M. H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice. PLoS Pathog. 4, e1000115 (2008).
131. Cilloniz, C. et al. Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog. 5, e1000604 (2009).
132. Baskin, C. R. et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl Acad. Sci. USA 106, 3455-3460 (2009).
133. Nakamura, R. et al. Interleukin-15 is critical in the pathogenesis of influenza a virus-induced acute lung injury. J. Virol. 84, 5574-5582 (2010).
134. Crowe, C. R. et al. Critical role of IL-17RA in immunopathology of influenza infection. J. Immunol. 183, 5301-5310 (2009).
135. Herold, S. et al. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand. J. Exp. Med. 205, 3065-3077 (2008).
136. Perrone, L. A., Szretter, K. J., Katz, J. M., Mizgerd, J. P. & Tumpey, T. M. Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. J. Infect. Dis. 202, 1161-1170 (2010).
137. Sun, K., Torres, L. & Metzger, D. W. A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection. J. Virol. 84, 5007-5014 (2010).
138. Sun, J., Madan, R., Karp, C. L. & Braciale, T. J. Effector T cells control lung inflammation during acute influenza virus infection by producing IL-10. Nature Med. 15, 277-284 (2009).
139. Salomon, R., Hoffmann, E. & Webster, R. G. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc. Natl Acad. Sci. USA 104, 12479-12481 (2007). (Pubitemid 47206163)
140. Manicassamy, B. et al. Analysis of in vivo dynamics of influenza virus infection in mice using a GFP reporter virus. Proc. Natl Acad. Sci. USA 107, 11531-11536 (2010).
141. WHO. Clinical features of severe cases of pandemic influenza. Pandemic (H1N1) 2009 briefing note 13. WHO Global Alert and Response [online], http://www. who.int/csr/disease/swineflu/notes/h1n1-clinical-features-20091016/ en/index.html (2009).
142. Rothberg, M. B. & Haessler, S. D. Complications of seasonal and pandemic influenza. Crit. Care Med. 38, e91-e97 (2010).
143. Carcione, D. et al. Comparison of pandemic (H1N1) 2009 and seasonal influenza, Western Australia, 2009. Emerg. Infect. Dis. 16, 1388-1395 (2010).
144. Peiris, J. S., Poon, L. L. & Guan, Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J. Clin. Virol. 45, 169-173 (2009).
145. Monsalvo, A. C. et al. Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nature Med. 17, 195-199 (2010).
146. Le, Q. M. et al. Avian flu: isolation of drug-resistant H5N1 virus. Nature 437, 1108 (2005). (Pubitemid 41509341)
147. Lemey, P., Suchard, M. & Rambaut, A. Reconstructing the initial global spread of a human influenza pandemic: a Bayesian spatial-temporal model for the global spread of H1N1pdm. PLoS Curr. 1, RRN1031 (2009).
148. Rambaut, A. & Holmes, E. The early molecular epidemiology of the swine-origin A/H1N1 human influenza pandemic. PLoS Curr. 1, RRN1003 (2009).
149. Jombart, T., Eggo, R. M., Dodd, P. & Balloux, F. Spatiotemporal dynamics in the early stages of the 2009 A/H1N1 influenza pandemic. PLoS Curr. 1, RRN1026 (2009).
150. Nelson, M. et al. The early diversification of influenza A/H1N1pdm. PLoS Curr. 1, RRN1126 (2009).
151. Vijaykrishna, D. et al. Reassortment of pandemic H1N1/2009 influenza A virus in swine. Science 328, 1529 (2010).
152. Vijaykrishna, D. et al. Long-term evolution and transmission dynamics of swine influenza A virus. Nature 473, 519-522 (2011).
153. Perez, J. T. et al. Influenza A virus-generated small RNAs regulate the switch from transcription to replication. Proc. Natl Acad. Sci. USA 107, 11525-11530 (2010).
154. Umbach, J. L., Yen, H. L., Poon, L. L. & Cullen, B. R. Influenza a virus expresses high levels of an unusual class of small viral leader RNAs in infected cells. mBio 1, e00204-e00210 (2010).